PharmaCyte Biotech (PMCB) had the highest return between February 1, 2009 and March 31, 2009 by a US stock, returning 116,150%.
| ASSET | DATE | % RETURN |
|---|---|---|
PharmaCyte Biotech (PMCB) | 2/1/2009 - 3/31/2009 | 116,150% |
Astrana Health (ASTH) | 2/1/2009 - 3/31/2009 | 6,166.67% |
OLB (OLB) | 2/1/2009 - 3/31/2009 | 300% |
Lifevantage (LFVN) | 2/1/2009 - 3/31/2009 | 287.48% |
Celsius (CELH) | 2/1/2009 - 3/31/2009 | 250.86% |
Sirius XM (SIRI) | 2/1/2009 - 3/31/2009 | 191.69% |
Smith & Wesson Brands (SWBI) | 2/1/2009 - 3/31/2009 | 159.48% |
CASI Pharmaceuticals (CASI) | 2/1/2009 - 3/31/2009 | 158.82% |
Pilgrims Pride (PPC) | 2/1/2009 - 3/31/2009 | 157.1% |
Citi Trends (CTRN) | 2/1/2009 - 3/31/2009 | 143.51% |
Sleep Number (SNBR) | 2/1/2009 - 3/31/2009 | 132.26% |
Insmed (INSM) | 2/1/2009 - 3/31/2009 | 127.27% |
Lendway (LDWY) | 2/1/2009 - 3/31/2009 | 127.27% |
Lixte Biotechnology (LIXT) | 2/1/2009 - 3/31/2009 | 120% |
TOMI Environmental Solutions (TOMZ) | 2/1/2009 - 3/31/2009 | 112.25% |
PEDEVCO (PED) | 2/1/2009 - 3/31/2009 | 110.53% |
ImmunoPrecise Antibodies (HYFT) | 2/1/2009 - 3/31/2009 | 110% |
QuickLogic (QUIK) | 2/1/2009 - 3/31/2009 | 109.36% |
Galectin Therapeutics (GALT) | 2/1/2009 - 3/31/2009 | 103.7% |
Abeona Therapeutics (ABEO) | 2/1/2009 - 3/31/2009 | 101.22% |
Lexaria Bioscience (LEXX) | 2/1/2009 - 3/31/2009 | 100% |
Dominari (DOMH) | 2/1/2009 - 3/31/2009 | 100% |
Bridgeline Digital (BLIN) | 2/1/2009 - 3/31/2009 | 98.24% |
Largo Resources (LGO) | 2/1/2009 - 3/31/2009 | 95.5% |
Savara (SVRA) | 2/1/2009 - 3/31/2009 | 94.23% |
